Steven L. Warner

Person

Sandy, UT, US

People

Patents Grantslast 30 patents

Information Patent Grant
ALK-5 inhibitors and uses thereof
- Patent number 11,746,103
- Issue date Sep 5, 2023
- Sumitomo Pharma Oncology, Inc.
- Bettina Franz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions comprising PKM2 modulators and methods of treatment us...
- Patent number 11,712,433
- Issue date Aug 1, 2023
- Sumitomo Pharma Oncology, Inc.
- Steven L. Warner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tyrosine kinase non-receptor 1 (TNK1) inhibitors and uses thereof
- Patent number 11,529,350
- Issue date Dec 20, 2022
- Sumitomo Pharma Oncology, Inc.
- Adam Siddiqui-Jain
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment regimen for cancers that are insensitive to BCL-2 inhibit...
- Patent number 11,497,756
- Issue date Nov 15, 2022
- Sumitomo Pharma Oncology, Inc.
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Formulations comprising heterocyclic protein kinase inhibitors
- Patent number 11,471,456
- Issue date Oct 18, 2022
- Sumitomo Pharma Oncology, Inc.
- Steven L. Warner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
AXL kinase inhibitors and use of the same
- Patent number 11,400,091
- Issue date Aug 2, 2022
- Sumitomo Pharma Oncology, Inc.
- Adam Siddiqui-Jain
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for treating diseases associated with abnormal ACVR1 expres...
- Patent number 11,040,038
- Issue date Jun 22, 2021
- SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
- Steven L. Warner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapies for treatment of cancer
- Patent number 10,835,537
- Issue date Nov 17, 2020
- SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
JAK1 and ALK2 inhibitors and methods for their use
- Patent number 10,752,594
- Issue date Aug 25, 2020
- SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
- Alexis Mollard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapies for treatment of cancer
- Patent number 10,682,356
- Issue date Jun 16, 2020
- Tolero Pharmaceuticals, Inc.
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Predicting response to alvocidib by mitochondrial profiling
- Patent number 10,624,880
- Issue date Apr 21, 2020
- Tolero Pharmaceuticals, Inc.
- Steven L. Warner
- G01 - MEASURING TESTING
Information Patent Grant
Combination therapies for treatment of cancer
- Patent number 10,568,887
- Issue date Feb 25, 2020
- Tolero Pharmaceuticals, Inc.
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Profiling peptides and methods for sensitivity profiling
- Patent number 10,422,788
- Issue date Sep 24, 2019
- Tolero Pharmaceuticals, Inc.
- David J. Bearss
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Predicting response to alvocidib by mitochondrial profiling
- Patent number 10,357,488
- Issue date Jul 23, 2019
- Tolero Pharmaceuticals, Inc.
- Steven L. Warner
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Profiling peptides and methods for sensitivity profiling
- Patent number 10,267,787
- Issue date Apr 23, 2019
- Tolero Pharmaceuticals, Inc.
- David J. Bearss
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
JAK2 and ALK2 inhibitors and methods for their use
- Patent number 10,202,356
- Issue date Feb 12, 2019
- Tolero Pharmaceuticals, Inc.
- Alexis Mollard
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Profiling peptides and methods for sensitivity profiling
- Patent number 10,132,797
- Issue date Nov 20, 2018
- Tolero Pharmaceuticals, Inc.
- David J. Bearss
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Predicting response to alvocidib by mitochondrial profiling
- Patent number 9,901,574
- Issue date Feb 27, 2018
- Tolero Pharmaceuticals, Inc.
- Steven L. Warner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted N-(3-pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosi...
- Patent number 9,828,376
- Issue date Nov 28, 2017
- University of Utah Research Foundation
- Hariprasad Vankayalapati
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Multiple kinase pathway inhibitors
- Patent number 9,714,247
- Issue date Jul 25, 2017
- Tolero Pharmaceuticals, Inc.
- Qingping Zeng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as hi...
- Patent number 9,642,857
- Issue date May 9, 2017
- University of Utah Research Foundation
- Hariprasad Vankayalapati
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as hi...
- Patent number 9,555,024
- Issue date Jan 31, 2017
- University of Utah Research Foundation
- Hariprasad Vankayalapati
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multiple kinase pathway inhibitors
- Patent number 9,493,454
- Issue date Nov 15, 2016
- Tolero Pharmaceuticals, Inc.
- Qingping Zeng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyros...
- Patent number 9,296,703
- Issue date Mar 29, 2016
- University of Utah Research Foundation
- Hariprasad Vankayalapati
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as hi...
- Patent number 9,266,838
- Issue date Feb 23, 2016
- University of Utah Research Foundation
- Hariprasad Vankayalapati
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyros...
- Patent number 9,206,176
- Issue date Dec 8, 2015
- University of Utah Research Foundation
- David J. Bearss
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Protein kinase inhibitors
- Patent number 8,999,988
- Issue date Apr 7, 2015
- Arizona Board of Regents on behalf of the University of Arizona
- Laurence H. Hurley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as hi...
- Patent number 8,987,335
- Issue date Mar 24, 2015
- University of Utah Research Foundation
- Hariprasad Vankayalapati
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted N-phenylpyrimidin-2-amine analogs as inhibitors of the...
- Patent number 8,901,120
- Issue date Dec 2, 2014
- University of Utah Research Foundation
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyros...
- Patent number 8,703,767
- Issue date Apr 22, 2014
- University of Utah Research Foundation
- David J. Bearss
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Combination Therapies for Treatment of Myelodysplastic Syndrome
- Publication number 20240382473
- Publication date Nov 21, 2024
- Sumitomo Pharma Oncology, Inc.
- Steven L. Warner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMIDAZO[1,2-B]PYRIDAZINYL COMPOUNDS AND USES THEREOF
- Publication number 20240360135
- Publication date Oct 31, 2024
- Sumitomo Pharma Oncology, Inc.
- Adam Siddiqui-Jain
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALK-5 Inhibitors and Uses Thereof
- Publication number 20240197729
- Publication date Jun 20, 2024
- Sumitomo Pharma Oncology, Inc.
- Bettina Franz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOLID DOSE PHARMACEUTICAL COMPOSITION
- Publication number 20240173319
- Publication date May 30, 2024
- Sumitomo Pharma Oncology, Inc.
- Steven L. WARNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Forms and Formulations Of A Tyrosine Kinase Non-Receptor 1 (TNK1) I...
- Publication number 20240091226
- Publication date Mar 21, 2024
- J. Micah Wilcox
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
JAK2 AND ALK2 INHIBITORS AND METHODS FOR THEIR USE
- Publication number 20240083855
- Publication date Mar 14, 2024
- SUMITOMO PHARMA AMERICA, INC.
- Alexis MOLLARD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALK5 INHIBITORS FOR TREATING MYELODYSPLASTIC SYNDROME
- Publication number 20240075033
- Publication date Mar 7, 2024
- Sumitomo Pharma Oncology, Inc.
- David J. BEARSS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOLID DOSE PHARMACEUTICAL COMPOSITION
- Publication number 20230390288
- Publication date Dec 7, 2023
- Sumitomo Pharma Oncology, Inc.
- Steven L. WARNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FORMULATIONS COMPRISING HETEROCYCLIC PROTEIN KINASE INHIBITORS
- Publication number 20230233557
- Publication date Jul 27, 2023
- Sumitomo Pharma Oncology, Inc.
- Steven L. WARNER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOLID DOSE PHARMACEUTICAL COMPOSITION
- Publication number 20230181586
- Publication date Jun 15, 2023
- Sumitomo Pharma Oncology, Inc.
- Steven L. WARNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AXL KINASE INHIBITORS AND USE OF THE SAME
- Publication number 20230165857
- Publication date Jun 1, 2023
- Sumitomo Pharma Oncology, Inc.
- Adam Siddiqui-Jain
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AMINOPYRIMIDINYLAMINOBENZONITRILE DERIVATIVES AS NEK2 INHIBITORS
- Publication number 20230090742
- Publication date Mar 23, 2023
- Sumitomo Pharma Oncology, Inc.
- Adam Siddiqui-Jain
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOLID DOSE PHARMACEUTICAL COMPOSITION
- Publication number 20230000864
- Publication date Jan 5, 2023
- Sumitomo Pharma Oncology, Inc.
- Steven L. WARNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AXL INHIBITOR FORMULATIONS
- Publication number 20220380348
- Publication date Dec 1, 2022
- Adam Siddiqui-Jain
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TREATING CASTRATION-RESISTANT AND CASTRATION-SENSITIVE...
- Publication number 20220339172
- Publication date Oct 27, 2022
- Sumitomo Pharma Oncology, Inc.
- Steven L. Warner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALK-5 INHIBITORS AND USES THEREOF
- Publication number 20220315563
- Publication date Oct 6, 2022
- Bettina Franz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPIES FOR TREATMENT OF CANCER
- Publication number 20210228582
- Publication date Jul 29, 2021
- SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AXL KINASE INHIBITORS AND USE OF THE SAME
- Publication number 20210205304
- Publication date Jul 8, 2021
- SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
- Adam Siddiqui-Jain
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MATERIALS AND METHODS FOR TREATING CANCER
- Publication number 20210145830
- Publication date May 20, 2021
- Mayo Foundation for Medical Education and Research
- Saad J. Kenderian
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PIM KINASE INHIBITORS FOR TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS...
- Publication number 20210113562
- Publication date Apr 22, 2021
- SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
- Jason Marc FOULKS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
JAK2 AND ALK2 INHIBITORS AND METHODS FOR THEIR USE
- Publication number 20210070715
- Publication date Mar 11, 2021
- SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
- Alexis Mollard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PREDICTING RESPONSE TO ALVOCIDIB BY MITOCHONDRIAL PROFILING
- Publication number 20210052568
- Publication date Feb 25, 2021
- SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
- Steven L. WARNER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Tyrosine Kinase Non-Receptor 1 (TNK1) Inhibitors and Uses Thereof
- Publication number 20210000825
- Publication date Jan 7, 2021
- Adam Siddiqui-Jain
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FORMULATIONS COMPRISING HETEROCYCLIC PROTEIN KINASE INHIBITORS
- Publication number 20200338076
- Publication date Oct 29, 2020
- TOLERO PHARMACEUTICALS, INC.
- Steven L. WARNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALK5 INHIBITORS FOR TREATING MYELODYSPLASTIC SYNDROME
- Publication number 20200323851
- Publication date Oct 15, 2020
- TOLERO PHARMACEUTICALS, INC.
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS TO TARGET TRANSCRIPTIONAL CONTROL AT SUPER-ENHANCER REGIONS
- Publication number 20200316084
- Publication date Oct 8, 2020
- TOLERO PHARMACEUTICALS, INC.
- Steven L. Warner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS COMPRISING PKM2 MODULATORS AND METHODS OF TREATMENT US...
- Publication number 20200297698
- Publication date Sep 24, 2020
- TOLERO PHARMACEUTICALS, INC.
- Steven L. WARNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TREATING CASTRATION-RESISTANT AND CASTRATION-SENSITIVE...
- Publication number 20200281949
- Publication date Sep 10, 2020
- TOLERO PHARMACEUTICALS, INC.
- Steven L. WARNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYCLIN-DEPENDENT KINASE INHIBITORS IN COMBINATION WITH ANTHRACYCLIN...
- Publication number 20200276174
- Publication date Sep 3, 2020
- TOLERO PHARMACEUTICALS, INC.
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT REGIMEN FOR CANCERS THAT ARE INSENSITIVE TO BCL-2 INHIBIT...
- Publication number 20200276215
- Publication date Sep 3, 2020
- TOLERO PHARMACEUTICALS, INC.
- David J. BEARSS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Steven L. Warner

Person

Patents Grantslast 30 patents

ALK-5 inhibitors and uses thereof

Compositions comprising PKM2 modulators and methods of treatment us...

Tyrosine kinase non-receptor 1 (TNK1) inhibitors and uses thereof

Treatment regimen for cancers that are insensitive to BCL-2 inhibit...

Formulations comprising heterocyclic protein kinase inhibitors

AXL kinase inhibitors and use of the same

Methods for treating diseases associated with abnormal ACVR1 expres...

Combination therapies for treatment of cancer

JAK1 and ALK2 inhibitors and methods for their use

Combination therapies for treatment of cancer

Predicting response to alvocidib by mitochondrial profiling

Combination therapies for treatment of cancer

Profiling peptides and methods for sensitivity profiling

Predicting response to alvocidib by mitochondrial profiling

Profiling peptides and methods for sensitivity profiling

JAK2 and ALK2 inhibitors and methods for their use

Profiling peptides and methods for sensitivity profiling

Predicting response to alvocidib by mitochondrial profiling

Substituted N-(3-pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosi...

Multiple kinase pathway inhibitors

Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as hi...

Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as hi...

Multiple kinase pathway inhibitors

Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyros...

Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as hi...

Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyros...

Protein kinase inhibitors

Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as hi...

Substituted N-phenylpyrimidin-2-amine analogs as inhibitors of the...

Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyros...

Patents Applicationslast 30 patents

Combination Therapies for Treatment of Myelodysplastic Syndrome

IMIDAZO[1,2-B]PYRIDAZINYL COMPOUNDS AND USES THEREOF

ALK-5 Inhibitors and Uses Thereof

SOLID DOSE PHARMACEUTICAL COMPOSITION

Forms and Formulations Of A Tyrosine Kinase Non-Receptor 1 (TNK1) I...

JAK2 AND ALK2 INHIBITORS AND METHODS FOR THEIR USE

ALK5 INHIBITORS FOR TREATING MYELODYSPLASTIC SYNDROME

SOLID DOSE PHARMACEUTICAL COMPOSITION

FORMULATIONS COMPRISING HETEROCYCLIC PROTEIN KINASE INHIBITORS

SOLID DOSE PHARMACEUTICAL COMPOSITION

AXL KINASE INHIBITORS AND USE OF THE SAME

AMINOPYRIMIDINYLAMINOBENZONITRILE DERIVATIVES AS NEK2 INHIBITORS

SOLID DOSE PHARMACEUTICAL COMPOSITION

AXL INHIBITOR FORMULATIONS

METHODS FOR TREATING CASTRATION-RESISTANT AND CASTRATION-SENSITIVE...

ALK-5 INHIBITORS AND USES THEREOF

COMBINATION THERAPIES FOR TREATMENT OF CANCER

AXL KINASE INHIBITORS AND USE OF THE SAME

MATERIALS AND METHODS FOR TREATING CANCER

PIM KINASE INHIBITORS FOR TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS...

JAK2 AND ALK2 INHIBITORS AND METHODS FOR THEIR USE

PREDICTING RESPONSE TO ALVOCIDIB BY MITOCHONDRIAL PROFILING

Tyrosine Kinase Non-Receptor 1 (TNK1) Inhibitors and Uses Thereof

FORMULATIONS COMPRISING HETEROCYCLIC PROTEIN KINASE INHIBITORS

ALK5 INHIBITORS FOR TREATING MYELODYSPLASTIC SYNDROME

METHODS TO TARGET TRANSCRIPTIONAL CONTROL AT SUPER-ENHANCER REGIONS

COMPOSITIONS COMPRISING PKM2 MODULATORS AND METHODS OF TREATMENT US...

METHODS FOR TREATING CASTRATION-RESISTANT AND CASTRATION-SENSITIVE...

CYCLIN-DEPENDENT KINASE INHIBITORS IN COMBINATION WITH ANTHRACYCLIN...

TREATMENT REGIMEN FOR CANCERS THAT ARE INSENSITIVE TO BCL-2 INHIBIT...